These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 25322652)
61. [The absence of tolerance and withdrawal syndrome after the treatment with the new L-tryptophane-containing dipeptide anxiolytic GB-115]. Kolik LG; Garibova TL; Litvinova SA; Kuznetsova AL; Kapitsa IG; Kadnikov IA; Konstantinopol'skiĭ MA; Gudasheva TA; Voronina TA; Seredenin SB Vestn Ross Akad Med Nauk; 2011; (7):37-42. PubMed ID: 21899090 [TBL] [Abstract][Full Text] [Related]
62. [Manifestations of the antinociceptive and anxiolytic properties of the compound GB-115: interactions of cholecystokinin and opioid systems]. Kolik LG; Zhukov VN; Seredenin SB Eksp Klin Farmakol; 2007; 70(2):8-11. PubMed ID: 17523442 [TBL] [Abstract][Full Text] [Related]
63. [Effect of GB-115 dipeptide on anxiety in rats with model benzodiazepine withdrawal syndrome]. Kolik LG; Kadnikov IA; Zhukov VN; Gudasheva TA; Seredenin SB Eksp Klin Farmakol; 2011; 74(10):7-11. PubMed ID: 22238979 [TBL] [Abstract][Full Text] [Related]
64. [Pharmacokinetics of three peroral dosage forms of new dipeptide anxiolytic drug GB-115]. Ivannikova EV; Boĭko SS; Zherdev VP; Raskin SIu; Blynskaia EV; Turchinskaia KG; Illarionov AA Eksp Klin Farmakol; 2014; 77(7):31-4. PubMed ID: 25322652 [TBL] [Abstract][Full Text] [Related]
65. [Pharmacokinetics and metabolism of tofizopam (Grandaxin)]. Klebovich I; Abermann M Acta Pharm Hung; 1993 Mar; 63(2):83-90. PubMed ID: 8100113 [TBL] [Abstract][Full Text] [Related]
66. [The mechanism of action of benzodiazepine and its consequences for therapy]. Cugurra F Clin Ter; 1992 Apr; 140(4):331-43. PubMed ID: 1350239 [TBL] [Abstract][Full Text] [Related]
67. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]